Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
ACE inhibitor |
| gptkbp:approvedBy |
1990s
|
| gptkbp:ATCCode |
gptkb:C09AA07
|
| gptkbp:brand |
gptkb:Cibacen
gptkb:Lotensin |
| gptkbp:CASNumber |
86541-74-4
|
| gptkbp:chemicalFormula |
C24H28N2O5
|
| gptkbp:contraindication |
pregnancy
history of angioedema |
| gptkbp:developedBy |
gptkb:Novartis
|
| gptkbp:eliminationHalfLife |
10-11 hours
|
| gptkbp:excretion |
urine
bile |
| https://www.w3.org/2000/01/rdf-schema#label |
benazepril
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits angiotensin-converting enzyme
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
424.49 g/mol
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:prodrugOf |
gptkb:benazeprilat
|
| gptkbp:proteinBinding |
96.7%
|
| gptkbp:PubChem_CID |
5362129
DB00542 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
cough hyperkalemia angioedema |
| gptkbp:UNII |
33X04XA5AT
|
| gptkbp:usedFor |
heart failure
hypertension |
| gptkbp:bfsParent |
gptkb:Cibacen
|
| gptkbp:bfsLayer |
5
|